Loading...
Under maintenance — back shortly
Ovarian cholesterol inhibition→androgen reduction→PCOS improvement
Atorvastatin reduces androgen levels and improves metabolic parameters in PCOS by inhibiting ovarian cholesterol synthesis required for androgen production; multiple clinical studies have confirmed this therapeutic benefit. This is a well-documented off-label use with clinical trial evidence.
“Atorvastatin treatment has been suggested as a therapeutic method for women with polycystic ovary syndrome (PCOS) in many clinical studies.”
— Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome: A systematic review and meta-analysis. (2021)DOI“In contrast, in the setting of polycystic ovary syndrome (PCOS), reducing excessive levels of androgens with atorvastatin could be beneficial.”
— Effect of atorvastatin on testosterone levels. (2021)DOI“Considering the network meta-analysis and rankings, atorvastatin was recommended to be the optimal drug for treatment PCOS.”
— Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis. (2023)DOI“The obtained results suggest that sisters of women with PCOS may benefit to a lesser degree from atorvastatin treatment than other women.”
— The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome. (2023)DOI“It is also used in the treatment of women with polycystic ovary syndrome (PCOS).”
— Metformin Therapy and Breast Cancer Incidence in the Ha'il Region. (2023)DOI